These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33957466)

  • 1. High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency.
    Ellingford JM; Telford N; Urquhart J; Will AM; Bonney D; Adams B; Dixon R; Kerr B; Black GC; Wynn RF; Meyer S
    Cancer Genet; 2021 Aug; 256-257():77-80. PubMed ID: 33957466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
    Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
    J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
    Rajput RV; Arnold DE
    Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
    An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
    [No Abstract]   [Full Text] [Related]  

  • 9. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.
    Al Seraihi AF; Rio-Machin A; Tawana K; Bödör C; Wang J; Nagano A; Heward JA; Iqbal S; Best S; Lea N; McLornan D; Kozyra EJ; Wlodarski MW; Niemeyer CM; Scott H; Hahn C; Ellison A; Tummala H; Cardoso SR; Vulliamy T; Dokal I; Butler T; Smith M; Cavenagh J; Fitzgibbon J
    Leukemia; 2018 Nov; 32(11):2502-2507. PubMed ID: 29749400
    [No Abstract]   [Full Text] [Related]  

  • 11. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
    Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
    Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
    Brambila-Tapia AJL; García-Ortiz JE; Brouillard P; Nguyen HL; Vikkula M; Ríos-González BE; Sandoval-Muñiz RJ; Sandoval-Talamantes AK; Bobadilla-Morales L; Corona-Rivera JR; Arnaud-Lopez L
    Hematology; 2017 Sep; 22(8):467-471. PubMed ID: 28271814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in children with
    Fisher KE; Hsu AP; Williams CL; Sayeed H; Merritt BY; Elghetany MT; Holland SM; Bertuch AA; Gramatges MM
    Blood Adv; 2017 Feb; 1(7):443-448. PubMed ID: 29296959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 Deficiency: Early Identification for Improved Clinical Outcomes.
    Cole K; Avila D; Parta M; Schuver B; Holland S; Shah N; Hickstein D
    Clin J Oncol Nurs; 2019 Aug; 23(4):417-422. PubMed ID: 31322613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.
    Kim N; Choi S; Kim SM; Lee AC; Im K; Park HS; Kim JA; Kim K; Kim I; Chang YH; Lee DS
    Leuk Lymphoma; 2019 Apr; 60(4):1053-1061. PubMed ID: 30714451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.